Browse By: Country ι Category ι Latest Reports ι Tag

Genomics And Proteomics Reagents, Research Kits and Analytical Instruments Market (Sample Preparation, Electrophoresis, BioChips and Microarrays, Chromatography, Mass Spectrometry, Thermal Cyclers, Next-Gen Sequencing) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019

Pages » 115
Published By » Transparency Market Research
Price » $4595
In stock
View Report Details
Description

Genomics and proteomics have greatly increased the volume and quality of information with regards to several lesser known genetic diseases and as such have expedited the cure for many illnesses. The market report encompasses the various technologies that account for genomics and proteomics research by various end users such as drug discovery and development, life-science research such as disease identification and diagnostics. The stakeholders for this study include market players who manufacture reagents and research kits, analytical tools and other products used in genomics and proteomics research. The market accounts for commercialized ready-to-use research kits to carry out variou... Click here for more details


Manufacturing of Biologics - Increasing Demand for Monoclonal Antibodies and Recombinant Proteins Drives Increases in Capacities and Innovative Production Technologies
GBI Research\'s report, “Manufacturing of Biologics - Increasing Demand for Monoclonal Antibodies and Recombinant Proteins Drives Increases in Capacities and Innovative Production Technologies”, provides the key data and analyzes the major challenges and drivers for the biomanufact
Published Date: Sep 2010
Price: $3500
Biomarkers in Cancer Research - High Unmet Need in Cervical Cancer and Lung Cancer to Drive Growth
GBI Research, the leading business intelligence provider, has released its latest report, “Biomarkers in Cancer Research - High Unmet Need in Cervical Cancer and Lung Cancer to Drive Growth” that provides key data, information and analysis of the major trends and issues affecti
Published Date: Sep 2010
Price: $3500
Nanotechnology in Drug Delivery - Technological Improvements and Novel Approaches to Fulfill High Potential
GBI Research, the leading business intelligence provider, has released its latest report, “Nanotechnology in Drug Delivery - Technological Improvements and Novel Approaches to Fulfill High Potential” that provides key data, information and analysis of the major trends and issues in
Published Date: Dec 2010
Price: $3500
Biotechnology Industry 2010 Yearbook - Top Biologics, Biosimilars, Licensing and Financing, Mergers and Acquisitions
GBI Research, the leading business intelligence provider, has released its latest report, “Biotechnology Industry 2010 Yearbook - Top Biologics, Biosimilars, Licensing and Financing, Mergers and Acquisitions” that provides key data, information and analysis of the major trends and
Published Date: Dec 2010
Price: $3500
Early Stage Drug Discovery in Disease Segments - Innovation Focuses on Stem Cell Therapies and Gene Therapies
GBI Researchs new report, Early Stage Drug Development in Disease Segments Innovation Focuses on Stem Cell Therapies and Gene Therapies, provides an in-depth analysis of the unmet needs, drivers and barriers that affect the global Central Nervous System Disorders (CNS), Metabolic Disorders, Immu
Published Date: Feb 2011
Price: $3500
Biobanks - 2011 Yearbook
GBI Research, the leading business intelligence provider, has released its latest research, Biobanks - 2011 Yearbook. It provides key data, information and analysis of the 40 major biobanks in the world. The report provides information on the population-based biobanks, disease based biobanks, brai
Published Date: Mar 2011
Price: $3500
Clinical Trial Endpoints in Oncology - Inclusion of Surrogate Endpoints and Shorter Endpoints Will Ensure Faster Clinical Trials in Oncology
GBI Research, the leading business intelligence provider, has released its latest research Clinical Trial Endpoints in Oncology Inclusion of Surrogate Endpoints and Shorter Endpoints will Ensure Faster Clinical Trials in Oncology, which essentially provides insights into clinical trial endpoints i
Published Date: Mar 2011
Price: $3500
Biosimilars Approval Pathways in the US and Europe - Development and Approval of Biosimilar mABs May Face Tough Regulatory Environment
GBI Research, the leading business intelligence provider, has released its latest report, Biosimilars Approval Pathways in the US and Europe Development and Approval of Biosimilar mAbs May Face Tough Regulatory Environment that provides key data, information and analysis of the major trends and is
Published Date: Apr 2011
Price: $3500
Cancer Supportive Care Products Market to 2016 - Market is Expected to Decline after 2014 Due to Generic Erosion and Entry of Biosimilars
GBI Research, the leading business intelligence provider, has released its latest research, Cancer Supportive Care Products Market to 2016 Market is Expected to Decline after 2014 Due to Generic Erosion and Entry of Biosimilars, which provides insights into the cancer supportive care products mark
Published Date: Apr 2011
Price: $3500
Orthobiologics Market to 2016 - Alternatives to Surgery and Superior Outcomes are Driving Wider Adoption of Orthobiologics
GBI Researchs new report, Orthobiologics Market to 2016 - Alternatives to Surgery and Superior Outcomes are Driving Wider Adoption of Orthobiologics provides key data, information and analysis on the Orthobiologics industry and analytical content on the market dynamics. The report provides mar
Published Date: Jun 2011
Price: $3500

 


 

Related News

Drug Resistance to be a Big Issue That is Faced by the Cancer Patients in Australia
According to the researchers, in the present scenario, drug resistance is one of the largest and toughest challenges facing the cancer patients, with the nation’s topmost medical researchers, who are looking and striving to determine that how aggressive the tumors are able to actually evade the established and conventional treatments. Karen Canfell, the researcher of Cancer Council NSW stated that the issue regarding the drug resistance has been growing along with the rising number of c
Date: May 26

China Plans To Cut the Reliance of Drugs in Hospitals for Income Generation
On Friday, the Chinese officials informed that a well-planned reform of health sector in China has been focusing at rooting out the corruption and also in reducing the dependency by hospitals on the drug prescriptions for generating income. The officials of Family Planning and National Health Commission stated that the reforms will be creating some new hospital revenue streams and also improve the hospital profits by providing the patients several service levels along with matching tiered cos
Date: May 26

Life Science Has Reported More Innovations than Technology
As per the analysis of Thomson Reuters of global patents, the industry of life sciences is growing tremendously and taking over from the technology sector in order to drive innovations across the globe. With an increasing number of patents applied for or even granted in the year 2014 than in any year known in the history, the humankind has never been so much inventive. The wide range comprises from designing innovative driverless cars, discovery of new drugs for cancer or even building bionic
Date: May 26

Paving New Silk Route to Alter Global Economy
Starting with the remarkable stories of Marco Polo’s travels through Eurasia to China, the Silk Road has always been in place to enter the world.  In modern times, the ancient cities of Baku, Samarkhand, Tashkent, and Bukhara are at this point pointing the world’s imagination. China has undertaken the massive construction and world’s economic development project: The New Silk Road. The project is all set to bring a revolutionary change in the economic picture of the
Date: May 26

Inadequate Office Space Shelves Exit Plans for UK-Based Banks
Inadequate availability of office spaces in rival European financial centers may alter plans of some of the London banks to quit the British capital and opt out of the European Union (EU) membership. As commented by the British prime minister, he has promised to work on Britain’s relationship with EU, and to come over a decision by 2017 to stay in the block or quit. Deutsche Bank, the second largest bank in the euro zone by assets, confirmed it was giving consideration to cut its UK
Date: May 26

Mega Budget Plan to Transform American City in 20 Years
Mayo Clinic, the world famous healthcare destination located in the small town of Rochester in Minnesota is ready for an ambitious developmental project.  There is widespread speculation if the project will transform the city into a global destination for medical tourism. It is so, as the wealthy European, Gulf Arab patients, American, and East Asian patrons at the clinic, are increasingly choosing other destinations either overseas or at domestic rivals such as Cleveland Clinic and J
Date: May 26

Sterile Mosquitoes Released to Tackle Dengue in Guangzhou, China
Chinese scientists have released more than half a million mosquitoes on a Guangzhou island in southern China from plastic ports on a truck, this spring. The scientist’s activity was welcomed by residents on the island and some even requested for the mosquitoes to be freed in their homes! The scientists are a part of an inventive move to tackle dengue fever through releasing sterile mosquitoes to diminish and alter the disease carrying mosquito population. Last year China had seen the na
Date: May 25

Experts Predict Smartphones’ Potential for Medical Related Benefits in Future
The untapped potential of smartphones’ to assist in connecting patients and doctors is among the most speculated topics in healthcare today. Apps and mobile devices could be used to revolutionize the methods of healthcare requests and delivery. Companies are eager to work through mobile technology owing to the huge numbers of smartphone users. The ways and means to tap the smartphone technologies is yet unclear according to experts. This is because of the sensitive privacy regulations rela
Date: May 25

HP becomes H3C in China
Due to its Chinese unit’s disappointing performance, Hewlett-Packard Co. (HP) has sold 51% stake in the unit worth US$4.5 billion to the technical arm of Beijing’s Tsinghua University. With the Chinese government’s focus on developing homegrown technology, HP is positive that the state-owned Chinese firm’s majority stake in the company will increase its sales. After the announcement of the deal and its plan to separate into two companies, the computer maker witnessed a ri
Date: May 25

Three New Chinese Smartphone Vendors Look at Indian Market
The slow growth story of the smart phone brands- ZTE, Huawei, and LG in India has not deterred Meizu, Phi-Comm, and Coolpad, the three popular players in the Chinese smartphone market to check the Indian waters. Indian smartphone market is growing at a rapid rate and is fiercely competitive. However, ZTE, Huawei, and LG, the top ranked global smartphone brands have not been very successful in establishing their presence in India which is dominated by Micromax and Samsung.  According to C
Date: May 25

Upcoming Reports

Hormone Replacement Therapy Market - Global Industry Size, Market Share, Trends, Analysis And Forecasts, 2012 - 2018
Hormone replacement therapy (HRT) is administration of hormones to those patients who are under a phase of declining natural hormones in their body. Hormone replacement therapy is mostly administered to women undergoing menopausal phase. The hormones which are administered to patients are most
Published By: Transparency Market Research
Price: $4795
Bio-Implants Market - Global Industry Analysis, Market Size, Market Share And Forecast, 2012 - 2018
Bio-implants are bioengineered products known to be of human or animal origin used in the different fields of ENT. Generally, these bio-implants are offered for safeguarding after tissue replacement. These bio-implants are made up of biosynthetic materials known as collagen or it can also be made
Published By: Transparency Market Research
Price: $4795
Biobanks Market - Global Industry Size, Market Share, Trends, Analysis And Forecast, 2012 - 2018
Biobanks is a collection or storation of blood and cell samples from a large number of people. Biobank collection denotes its use in medical field and research. The global biobank industry is segmented into different sectors such as human tissue banking, or population banking, stem cell banking, c
Published By: Transparency Market Research
Price: $4795
Orthobiological Products Market - Global Industry Analysis, Market Size, Market Share And Forecasts, 2012 - 2018
The global orthobiological products market is expected to grow to $15.3 billion by the year 2022 as a result of tremendous growth in the medical devices industry mainly due to increase in aging population. Growth of orthobiological products is driven by increasing awareness towards adoption of ort
Published By: Transparency Market Research
Price: $4795
Gene Amplification Technologies Market - Global Industry Analysis, Market Size, Market Share And Forecasts, 2012 - 2018
Gene amplification technology is proving to be an important technology in human genome projects and other important fields like diagnostics. There are number of companies involved in the business of gene amplification and diagnostics with over 30 gene and signal amplification technologies. These g
Published By: Transparency Market Research
Price: $4795
DNA Sequencing Market - Global Industry Analysis, Market Size, Market Share And Forecasts, 2012 - 2018
The global DNA sequencing market is forecast to grow to $6.6 billion over the year 2016 at the compounded annual growth rate of 17.5% as a result of emerging technologies in this field and its use in a number of applications.   DNA sequencing industry is segmented into instruments and consu
Published By: Transparency Market Research
Price: $4795
Epigenetics Market - Global Industry Analysis, Market Size, Market Share And Forecasts, 2012 - 2018
The global epigenetics market is projected to reach the value of $18.2 billion by the year 2015 driven by investigation of factors influencing cellular malfunction and disease development. Also, developments in epigenetic studies like biomarker discovery and scientifically useful biomarker tests a
Published By: Transparency Market Research
Price: $4795
Biologics Market - G7 Industry Size, Market Share, Trends, Analysis, And Forecasts 2012 - 2018
With an increase in the number of clinical trials in the past 5 years, the market for biologics is expected to witness a high growth during the coming years. Monoclonal antibodies, vaccines and therapeutic proteins will contribute significantly to the growth in the biologics market. The global
Published By: Transparency Market Research
Price: $4795
Biosimilar and Follow-On Biologics Market - Global Industry Size, Market Share, Trends, Analysis And Forecasts 2012 - 2018
There is a rising demand for low cost biological drugs. Commercial and regulatory developments are taking the follow-on biologics market to new heights. Drug manufacturers are exploring the possibilities of producing generic biopharmaceuticals drugs with a motive of reducing the prices of thes
Published By: Transparency Market Research
Price: $4795
Biopesticides Market - Global Industry Analysis, Market Size, Market Share And Forecasts, 2012 - 2018
Biopesticides are essential for controlling the effect of agricultural pests, insects, and bacterial and fungal growth on food and field crops. Use of biopesticides can avoid the hazards caused by the use of chemical pesticides on the environment. Growing environmental concerns and stringent r
Published By: Transparency Market Research
Price: $4795